These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21824932)

  • 1. Biomarkers in clinical trials: can we move from fortune telling to disease profiling?
    de Lemos JA; McGuire DK
    Circulation; 2011 Aug; 124(6):663-5. PubMed ID: 21824932
    [No Abstract]   [Full Text] [Related]  

  • 2. Updates on cardiovascular outcome trials in diabetes.
    Schnell O; Rydén L; Standl E; Ceriello A;
    Cardiovasc Diabetol; 2017 Oct; 16(1):128. PubMed ID: 29020969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A search for novel pathways of effective prevention of cardiovascular complications in patients with type 2 diabetes mellitus: advance trial].
    Karpov IuA; Shubina AT
    Kardiologiia; 2007; 47(10):90-5. PubMed ID: 18260953
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of T2DM in 2017: Clinically relevant results from cardiovascular outcome trials.
    Holman RR
    Nat Rev Endocrinol; 2018 Feb; 14(2):67-68. PubMed ID: 29302077
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy and clinical trials: glycaemic control and cardiovascular disease.
    Edavalath M; Rees A
    Curr Opin Lipidol; 2009 Dec; 20(6):530-1. PubMed ID: 19935205
    [No Abstract]   [Full Text] [Related]  

  • 6. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
    Sherman FT
    Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes: Time for reconciliation between cardiologists and diabetologists.
    Scheen AJ
    Nat Rev Cardiol; 2016 Sep; 13(9):509-10. PubMed ID: 27411401
    [No Abstract]   [Full Text] [Related]  

  • 8. Results from Cardiovascular Outcome Trials in Diabetes.
    Muñoz Torres M; Muñoz Garach A
    Endocrinol Nutr; 2016; 63(7):317-9. PubMed ID: 27324936
    [No Abstract]   [Full Text] [Related]  

  • 9. Incretin-based therapy for type 2 diabetes: A real class effect?
    Savarese G; Lund LH; Rosano GMC
    Int J Cardiol; 2017 Jan; 227():141-142. PubMed ID: 27866064
    [No Abstract]   [Full Text] [Related]  

  • 10. SGLT2 inhibitors: new reports.
    Med Lett Drugs Ther; 2015 Oct; 57(1479):139-40. PubMed ID: 26445203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality of healthcare in type 2 diabetes mellitus in Spain].
    Soriguer F; Ruiz de Adana MS
    Med Clin (Barc); 2012 May; 138(12):522-4. PubMed ID: 22118976
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular safety evaluation in the development of new drugs for diabetes mellitus.
    Menon V; Lincoff AM
    Circulation; 2014 Jun; 129(25):2705-13. PubMed ID: 24958753
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment.
    Gore MO; McGuire DK
    Diab Vasc Dis Res; 2012 Apr; 9(2):85-8. PubMed ID: 22496441
    [No Abstract]   [Full Text] [Related]  

  • 14. [Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus].
    Ametov AS; P'ianykh OP; Chernikova NA
    Ter Arkh; 2010; 82(8):71-5. PubMed ID: 20873250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular trials and diabetes treatments: a regulatory maze.
    Matthews DR
    Diab Vasc Dis Res; 2012 Apr; 9(2):83-4. PubMed ID: 22419242
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome results renew debate about diabetes drug development.
    Mullard A
    Lancet Diabetes Endocrinol; 2013 Nov; 1(3):179-80. PubMed ID: 24622363
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [World news in age-related diabetes: blood sugar lowering can improve prognosis].
    Einecke D
    MMW Fortschr Med; 2005 Sep; 147(38):1. PubMed ID: 16218218
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles.
    Wurm R; Resl M; Neuhold S; Prager R; Brath H; Francesconi C; Vila G; Strunk G; Clodi M; Luger A; Pacher R; Hülsmann M
    Heart; 2016 Oct; 102(19):1544-51. PubMed ID: 27226327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.